Can a tailored lifestyle plan outsmart Obesity-Related health risks?

NCT ID NCT07742917

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether a personalized lifestyle medicine program can improve cardiometabolic health in Emirati adults aged 25-50 with obesity. Participants receive an 18-week program tailored to their individual health screening results, with follow-up over 24 weeks. The study compares them to a similar group receiving standard care to see if the personalized approach leads to greater improvements in weight, blood sugar, cholesterol, and blood pressure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Precision Lifestyle Medicine Program (behavioral intervention)
What this could lead to
If successful, this could show that personalized lifestyle coaching based on individual health screening can meaningfully reduce risks for heart disease and type 2 diabetes in people with obesity.
What could go wrong
This is a relatively small, early-stage trial, and the program's success depends on participants sticking with lifestyle changes. Results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BMI/BODY COMPOSITION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institute for Healthier Living

    RECRUITING

    Abu Dhabi, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.